Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2698770 | 0.89 | TSHR (0.54) | CYP1A2CYP2C19MEN1KMT2APOLB | |
| SCHEMBL11464001 | 0.82 | TSHR (0.54) | CYP1A2CYP2C19MEN1KMT2ATSHR | |
| SCHEMBL2703372 | 0.82 | CYP1A2 (0.53) | CYP1A2CYP2C19MEN1KMT2ATSHR | |
| SCHEMBL23736317 | 0.78 | POLB (0.53) | CYP1A2CYP2C19MEN1KMT2APOLB | |
| SCHEMBL9395070 | 0.77 | POLB (0.72) | CYP1A2CYP2C19MEN1KMT2APOLB | |
| SCHEMBL28423617 | 0.76 | TSHR (0.60) | CYP1A2CYP2C19MEN1KMT2ATSHR | |
| SCHEMBL26134815 | 0.76 | TSHR (0.69) | CYP1A2CYP2C19TSHRALDH1A1L3MBTL1 | |
| SCHEMBL11543540 | 0.75 | ALDH1A1 (0.48) | MEN1KMT2ATSHRRAB9ANPC1 | |
| SCHEMBL5697535 | 0.75 | NR4A1 (0.61) | CYP1A2CYP2C19MEN1KMT2ANR4A1 | |
| SCHEMBL10445015 | 0.75 | TP53 (0.58) | MEN1KMT2APOLBRAB9ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120138907-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2012-06-07 | — | — | US | disclosed |
| EP-2450356-A1 | Carbazole and anthracene moiety containing light-emitting device material and light-emitting devices | Toray Industries, Inc. (JP) | 2012-05-09 | — | — | EP | disclosed |
| EP-1748045-B1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES (JP) | 2012-05-02 | — | — | EP | disclosed |
| US-8084146-B2 | Light-emitting device material and light-emitting device | TORAY INDUSTRIES, INC. (JP) | 2011-12-27 | — | — | US | disclosed |
| US-20070247063-A1 | Light-Emitting Device Material and Light-Emitting Device | TORAY INDUSTRIES INC. (JP) | 2007-10-25 | — | — | US | disclosed |
| EP-1748045-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | TORAY INDUSTRIES, INC. (JP) | 2007-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120138907-A1 | LIGHT-EMITTING DEVICE MATERIAL AND LIGHT-EMITTING DEVICE | CRY1, MMS19, CRY2 | CYP1A2 400/4885CYP2C19 49/4885MEN1 469/4885 |
| US-20070247063-A1 | Light-Emitting Device Material and Light-Emitting Device | CRY1, CRY2, ATXN10 | CYP1A2 201/4885CYP2C19 78/4885MEN1 1379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.